RESDAARVY

Serial Number 90876669
606

Registration Progress

Application Filed
Aug 11, 2021
Under Examination
Nov 30, 2021
Approved for Publication
Oct 5, 2021
Published for Opposition
Oct 5, 2021
Registered

Trademark Image

RESDAARVY

Basic Information

Serial Number
90876669
Filing Date
August 11, 2021
Published for Opposition
October 5, 2021
Abandonment Date
December 30, 2024
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Dec 30, 2024
Classes
005

Rights Holder

Atea Pharmaceuticals, Inc.

03
Address
225 Franklin Street, Suite 2100
Boston, MA 02110

Ownership History

Atea Pharmaceuticals, Inc.

Original Applicant
03
Boston, MA

Atea Pharmaceuticals, Inc.

Owner at Publication
03
Boston, MA

Legal Representation

Attorney
Theodore H. Davis Jr.

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

37 events
Date Code Type Description Documents
Dec 30, 2024 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Dec 30, 2024 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
May 15, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
May 14, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 13, 2024 EX5G S SOU EXTENSION 5 GRANTED Loading...
May 13, 2024 EXT5 S SOU EXTENSION 5 FILED Loading...
May 13, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 1, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 29, 2023 EXT4 S SOU EXTENSION 4 FILED Loading...
Nov 29, 2023 EX4G S SOU EXTENSION 4 GRANTED Loading...
Nov 29, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 27, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 25, 2023 EX3G S SOU EXTENSION 3 GRANTED Loading...
Apr 25, 2023 EXT3 S SOU EXTENSION 3 FILED Loading...
Apr 25, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 7, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 5, 2022 EX2G S SOU EXTENSION 2 GRANTED Loading...
Oct 5, 2022 EXT2 S SOU EXTENSION 2 FILED Loading...
Oct 5, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 8, 2022 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Sep 8, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Sep 8, 2022 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Apr 13, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 11, 2022 EX1G S SOU EXTENSION 1 GRANTED Loading...
Apr 11, 2022 EXT1 S SOU EXTENSION 1 FILED Loading...
Apr 11, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 30, 2021 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Oct 5, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Oct 5, 2021 PUBO A PUBLISHED FOR OPPOSITION Loading...
Sep 15, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Sep 2, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 2, 2021 PCGR O PETITION TO DIRECTOR GRANTED Loading...
Sep 2, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Sep 2, 2021 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Aug 30, 2021 APET A ASSIGNED TO PETITION STAFF Loading...
Aug 26, 2021 TPDR I TEAS PETITION TO DIRECTOR RECEIVED Loading...
Aug 14, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations, namely, antivirals

Classification

International Classes
005